• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[特发性垂体功能减退症的最终身高与青春期]

[Final body height and puberty in idiopathic hypopituitarism].

作者信息

Gács G

出版信息

Orv Hetil. 1989 Feb 19;130(8):383-7.

PMID:2646572
Abstract

Twenty four children with hypopituitarism were treated with growth hormone from 6-15 years of age until cessation of growth. The height deficit decreased from -4.2SD to -2.2SD. Final height was above the 3rd percentile in half of the patients. There was no difference in final height between patients with and without additional gonadotropin deficiency. Spontaneous puberty started late but at a normal bone age and its course was normal. In girls with gonadotropin deficiency low dose oestrogen given at unchanged growth hormone doses did not accelerate growth. Final height was closely correlated with the degree of growth retardation at the beginning of treatment (r = 0.73, p less than 0.001). In 17 of the 79 patients treated with growth hormone compliance was bad. The main cause of bad compliance was the low educational level of the parents. It is concluded that final height in growth hormone deficiency can be increased with earlier diagnosis and improved compliance.

摘要

24名垂体功能减退的儿童在6至15岁期间接受生长激素治疗,直至生长停止。身高缺陷从-4.2标准差降至-2.2标准差。半数患者的最终身高高于第3百分位。伴有和不伴有额外促性腺激素缺乏的患者最终身高无差异。自发青春期开始较晚,但骨龄正常,其过程正常。对于促性腺激素缺乏的女孩,在生长激素剂量不变的情况下给予低剂量雌激素并不能加速生长。最终身高与治疗开始时的生长迟缓程度密切相关(r = 0.73,p < 0.001)。在79名接受生长激素治疗的患者中,有17名依从性差。依从性差的主要原因是父母教育水平低。结论是,通过早期诊断和改善依从性,可以提高生长激素缺乏患者的最终身高。

相似文献

1
[Final body height and puberty in idiopathic hypopituitarism].[特发性垂体功能减退症的最终身高与青春期]
Orv Hetil. 1989 Feb 19;130(8):383-7.
2
[Evaluation of final height in patients with pituitary growth hormone deficiency who were treated with growth hormone replacement].[生长激素替代治疗的垂体生长激素缺乏症患者最终身高的评估]
Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw. 2006;12(1):31-4.
3
[Adult height of patients after long-term treatment of idiopathic growth hormone deficiency. (Czech Registry 1991-1998)].[特发性生长激素缺乏症患者长期治疗后的成人身高。(捷克登记处,1991 - 1998年)]
Cas Lek Cesk. 2000 Aug 30;139(17):529-32.
4
Final height outcome of growth hormone-deficient patients treated since less than five years of age.五岁前开始治疗的生长激素缺乏症患者的最终身高结果
Acta Paediatr. 1996 Oct;85(10):1167-71.
5
Acromegalic features in growth hormone (GH)-deficient patients after long-term GH therapy.长期生长激素(GH)治疗后生长激素缺乏患者出现肢端肥大症特征。
Clin Endocrinol (Oxf). 2003 Dec;59(6):788-92. doi: 10.1046/j.1365-2265.2003.01899.x.
6
Adult height in children with growth hormone deficiency who are treated with biosynthetic growth hormone: the National Cooperative Growth Study experience.接受生物合成生长激素治疗的生长激素缺乏症儿童的成人身高:全国合作生长研究经验。
Pediatrics. 1998 Aug;102(2 Pt 3):512-6.
7
[Retrospective comprehensive assessment of the treatment effect of children with growth hormone deficiency].[生长激素缺乏症患儿治疗效果的回顾性综合评估]
Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw. 2005;11(3):161-9.
8
The results of long-term growth hormone replacement therapy in Turkish children with growth hormone deficiency.土耳其生长激素缺乏症儿童长期生长激素替代疗法的结果
Turk J Pediatr. 1998 Jan-Mar;40(1):55-60.
9
Combined use of growth hormone and gonadotropin-releasing hormone analogues: the national cooperative growth study experience.生长激素与促性腺激素释放激素类似物的联合使用:全国合作生长研究经验
Pediatrics. 1999 Oct;104(4 Pt 2):1014-8.
10
Final height in children with idiopathic growth hormone deficiency treated with a fixed dose of recombinant growth hormone.接受固定剂量重组生长激素治疗的特发性生长激素缺乏症儿童的最终身高
Horm Res. 2007;68(5):236-43. doi: 10.1159/000101427. Epub 2007 Mar 29.